Skip to main content

Vishnukamal Golla

Medical Assistant Professor in the Department of Urology
Urology

Overview


I am a board certified urologist who is a currently a fellow in the Duke University National Clinician Scholars Program (NCSP) which is the one of the premier health services research programs in the country. I have been awarded several grants studying the quality of care in the U.S including the American Urological Association Residency Research Award and the HH Lee Surgical Research Award. This work informed targets for improved patient outcomes in bladder cancer patient service lines and health policy relevant targets for improving guideline concordant care in this population.

As a Duke NCSP fellow, I am partnered with the Division of Urology, Duke Margolis Policy Center, Duke Cancer Research Institute, Duke-CTSI, and the Durham VA to continue my work in the population science and health policy centered around shifting specialty care into value-based models that incentivize higher quality, lower costs of care that aligns financial incentives with outcomes that matter to patients. I will continue to provide clinical care and resident education as a Clinical instructor in the Division of Urology at the Durham VA. My career goal is to transform the healthcare payment and delivery system to drive high quality, affordable healthcare while improving the patient and provider experience.

Education/Training:
B.A., University of Southern California, 2010
MD, MPH University of Texas at Houston Medical School, 2015
Residency, Urology, University of California at Los Angeles, 2015-2021
Fellow, National Clinician Scholars Program, Duke University, 2021-2023



Current Appointments & Affiliations


Medical Assistant Professor in the Department of Urology · 2025 - Present Urology, Clinical Science Departments
Core Faculty Member, Duke-Margolis Institute for Health Policy · 2024 - Present Duke-Margolis Institute for Health Policy, University Initiatives & Academic Support Units

Recent Publications


Payment Bundles for Prostatectomy: A New Way to Improve Value for Prostate Cancer Care.

Journal Article Urology · March 21, 2025 American healthcare expenditures exceed $4 trillion annually, with prostate cancer (PCa) accounting for $22 billion. Prostatectomy, a common treatment for PCa, incurs significant cost variability. Value-based care (VBC), emphasizing outcomes and efficiency ... Full text Link to item Cite

Design of Payment and Reimbursement Strategies for Focal Therapy for Acceptance in Value-Based Care Models

Chapter · January 1, 2025 Value-based care payment models provide an opportunity to curb rising healthcare costs. However, there are limited examples of these models in practice for specialty care, even for common and expensive urologic conditions, such as prostate cancer. As the u ... Full text Cite

Long-Term Trends in Decisional Regret Among Men with Localized Prostate Cancer

Journal Article JU Open Plus · April 2024 Purpose:There are several evidence-based treatment options for localized prostate cancer (PCa). Decisional regret (DR), or regret based on the treatment a patient chooses, is poorly under ... Full text Cite
View All Publications

Education, Training & Certifications


University of Texas Health Sciences Center, Houston · 2015 MD.M.P.H.